Resectable adenocarcinoma of the rectosigmoid and rectum. I. Patterns of failure and survival
- PMID: 3345493
- DOI: 10.1002/1097-0142(19880401)61:7<1408::aid-cncr2820610722>3.0.co;2-a
Resectable adenocarcinoma of the rectosigmoid and rectum. I. Patterns of failure and survival
Abstract
In an effort to determine the patterns of failure and survival of rectosigmoid and rectal cancer, a retrospective review of 168 patients who underwent potentially curative surgery at the New England Deaconess Hospital was performed. The 5-year actuarial survival for the entire group was 67%. Survival rates decreased with increasing penetration of the bowel wall by tumor and the presence of lymph node metastasis, but only the latter reached statistical significance. Those patients who underwent an abdominoperineal resection also experienced a significant decrease in survival compared to a low anterior resection. Patterns of failure, expressed as the actuarial incidence of first failure at 5 years, were examined by stage. With the exception of stages B3 and C3, there was a trend towards increased abdominal, distant, and total failure with increasing bowel wall penetration by tumor. A similar trend was seen in local failure in those patients with positive nodes. Knowledge of these data may help identify those patients who may benefit most from adjuvant therapy.
Similar articles
-
Resectable adenocarcinoma of the rectosigmoid and rectum. II. The influence of blood vessel invasion.Cancer. 1988 Apr 1;61(7):1417-24. doi: 10.1002/1097-0142(19880401)61:7<1417::aid-cncr2820610723>3.0.co;2-9. Cancer. 1988. PMID: 3345494
-
Outcomes of resection of stage IV rectal cancer with mesorectal excision.J Surg Oncol. 2006 Jun 1;93(7):523-8. doi: 10.1002/jso.20506. J Surg Oncol. 2006. PMID: 16705728
-
Anterior resection for rectal cancer with mesorectal excision: a prospective evaluation of 622 patients.Ann Surg. 2004 Aug;240(2):260-8. doi: 10.1097/01.sla.0000133185.23514.32. Ann Surg. 2004. PMID: 15273550 Free PMC article.
-
A systematic review and meta-analysis comparing surgical and oncological outcomes of upper rectal, rectosigmoid and sigmoid tumours.Eur J Surg Oncol. 2021 Sep;47(9):2421-2428. doi: 10.1016/j.ejso.2021.05.011. Epub 2021 May 12. Eur J Surg Oncol. 2021. PMID: 34016500
-
Reflections in rectosigmoid: retro-peritoneal vs. intra-peritoneal.Int J Radiat Oncol Biol Phys. 1988 May;14(5):1043-6. doi: 10.1016/0360-3016(88)90030-2. Int J Radiat Oncol Biol Phys. 1988. PMID: 3283082 Review. No abstract available.
Cited by
-
Neoadjuvant hyperfractionated accelerated radiotherapy plus concomitant 5-fluorouracil infusion in locally advanced rectal cancer: A phase II study.World J Gastrointest Oncol. 2018 Jan 15;10(1):40-47. doi: 10.4251/wjgo.v10.i1.40. World J Gastrointest Oncol. 2018. PMID: 29375747 Free PMC article.
-
Patterns of recurrence following liver resection for colorectal metastases: effect of primary rectal tumor site.Arch Surg. 2008 Aug;143(8):743-9; discussion 749-50. doi: 10.1001/archsurg.143.8.743. Arch Surg. 2008. PMID: 18711033 Free PMC article.
-
Post-Resection Surveillance in GI Cancers.Indian J Surg. 2014 Oct;76(5):382-91. doi: 10.1007/s12262-013-0943-z. Epub 2013 Jul 11. Indian J Surg. 2014. PMID: 26396472 Free PMC article. Review.
-
Prognostic Value of Clinical vs Pathologic Stage in Rectal Cancer Patients Receiving Neoadjuvant Therapy.J Natl Cancer Inst. 2018 May 1;110(5):460-466. doi: 10.1093/jnci/djx228. J Natl Cancer Inst. 2018. PMID: 29165692 Free PMC article.
-
Adjuvant and neoadjuvant chemoradiation or radiotherapy in rectal cancer--a review focusing on open questions.Int J Colorectal Dis. 2008 Mar;23(3):227-36. doi: 10.1007/s00384-007-0419-3. Epub 2007 Dec 7. Int J Colorectal Dis. 2008. PMID: 18064471 Review.
Publication types
MeSH terms
LinkOut - more resources
Miscellaneous